Literature DB >> 27885751

Effect of PR Interval on Outcomes Following Cardiac Resynchronization Therapy: A Secondary Analysis of the COMPANION Trial.

Jeffrey Lin1, Kevin A Buhr2, Ryan Kipp1.   

Abstract

BACKGROUND: Prolonged PR intervals may impair atrioventricular mechanical coupling and adversely affect cardiac performance. We hypothesize that patients with advanced systolic heart failure, wide QRS complexes, and prolonged PR intervals will have improved survival from CRT-D regardless of whether left bundle branch block (LBBB) or non-LBBB is present. METHODS AND
RESULTS: A total of 308 patients enrolled in the optimal pharmacologic therapy (OPT) and 595 patients in the cardiac resynchronization therapy with defibrillation (CRT-D) arms of the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure trial were stratified according to normal (≤230 ms) or prolonged PR interval (>230 ms). The incidence of all-cause mortality (ACM) or hospitalization (primary endpoint) and ACM (secondary endpoint) was compared using Kaplan-Meier curves. Cox proportional hazards models for the primary and secondary endpoints were fit with LBBB status and baseline PR interval. CRT-D treatment reduced both hospitalization/ACM (P = 0.002) and ACM (P = 0.003) compared to OPT. However, CRT-D was increasingly more effective in reducing ACM hazard in patients with longer baseline PR intervals (P = 0.002) regardless of LBBB status. In particular, in the prolonged baseline PR interval subgroup, ACM was reduced with CRT-D compared to OPT (P = 0.001) with little evidence of ACM reduction in the normal PR subgroup (P = 0.07).
CONCLUSIONS: In patients with advanced systolic heart failure, wide QRS complexes, and prolonged PR intervals, restoration of atrioventricular mechanical coupling with CRT-D may improve survival regardless of LBBB status. In patients with non-LBBB, a benefit from CRT-D may occur with prolonged PR intervals. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  COMPANION trial; PR interval; cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator

Mesh:

Substances:

Year:  2017        PMID: 27885751     DOI: 10.1111/jce.13131

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

Review 1.  Re-evaluating the electro-vectorcardiographic criteria for left bundle branch block.

Authors:  Andrés Ricardo Pérez-Riera; Raimundo Barbosa-Barros; Rodrigo Daminello-Raimundo; Luiz Carlos de Abreu; Marcos Célio de Almeida; Jani Rankinen; Fabio Baeub Soler; Kjell Nikus
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-04-02       Impact factor: 1.468

Review 2.  Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns?

Authors:  Mark N Belkin; Gaurav A Upadhyay
Journal:  Curr Cardiol Rep       Date:  2017-10-24       Impact factor: 2.931

3.  Multi-lead pacing for cardiac resynchronization therapy in heart failure: a meta-analysis of randomized controlled trials.

Authors:  Mark K Elliott; Vishal Mehta; Nadeev Wijesuriya; Baldeep S Sidhu; Justin Gould; Steven Niederer; Christopher A Rinaldi
Journal:  Eur Heart J Open       Date:  2022-02-26

4.  Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.

Authors:  Mohamad El Moheb; Johny Nicolas; Assem M Khamis; Ghida Iskandarani; Elie A Akl; Marwan Refaat
Journal:  Cochrane Database Syst Rev       Date:  2018-12-08

5.  Prolonged PR Interval and Outcome in Cardiac Resynchronization Therapy.

Authors:  Jakrin Kewcharoen; Chanavuth Kanitsoraphan
Journal:  Arq Bras Cardiol       Date:  2019-08-08       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.